XNK Therapeutics
Hans Ericson is a Senior Finance professional with more than 20 years’ experience in international business and stock listed companies, with proven leadership in Controllership and Finance. He has had a number of leading positions primarily in Ericsson and Elekta, where he had the position as Group Controller for a long period of time. Hans has also been a consultant and have had assignments in various areas such as start-ups and large research organisations such as RISE.
This person is not in any offices
XNK Therapeutics
XNK Therapeutics is focused on realizing the potential in autologous NK cell therapies for cancer patients.